AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05600621 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Financial Literacy Training (FLT) Workshops
Description: Participants will be assigned to receive FLT workshops which are implemented by community-level agencies in collaboration with the financial institutions. FLT comprises six workshops delivered over 6 weeks. Topics include: a) an introduction to the notion of asset-building; b) coverage of asset-building strategies in detail, e.g., saving; c) coverage of specific topics related to saving, e.g., the importance of saving and how to save, d) an introduction of banking services to participants and e) coverage of basics of borrowing and debt management. Participants from the same location, in this case, clinics are assigned to the same group. Workshops occur on weekends to accommodate participants week-day schedules, including school and/or gardening.
Study NCT05036785 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Timing of suture removal
Description: Patients will either be randomized to have their sutures removed at 7 or 10 days post skin surgery
Study NCT05737732 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Circadian Ineffective Lightning (CIL)
Description: Participants will receive lower lighting levels in the morning (lighting with A spectrum of 300k, \<50lux to the eye level between 7:00am and 10:00am) and the same lighting levels throughout the rest of the day.
Study NCT06107829 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valbenazine Oral Capsule
Description: Open-label twenty-four-week treatment with valbenazine oral capsules (up to 80 mg/day) to test the safety and effectiveness of this medication in ameliorating the signs of tardive dyskinesia in persons with intellectual disability.
Study NCT06004804 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emotional Awareness and Expression Therapy
Description: Seeks to reduce physical (e.g., pain) and emotional (e.g., depression, anxiety) symptoms by helping individuals become aware of their emotions, express them, and resolve emotional conflicts. It will use techniques such as writing about stress, role playing how to handle difficult relationships, recognizing and expressing anger and other feelings, and being more open with others.
Study NCT06004804 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation
Description: Seeks to help individuals achieve present moment awareness, self-compassion, and acceptance of chronic pain. It will use techniques such as the body scan, grounding, mindful breathing, mindful walking, loving kindness, and compassionate breathing.
Study NCT06004804 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Behavioral Therapy
Description: Seeks to help individuals function better and improve symptoms by teaching various cognitive and behavioral skills to manage symptoms. It will use techniques such as relaxation training, engaging in pleasant activities, pacing yourself, and changing unhelpful ways of thinking.
Study NCT04333966 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interactive Social Networking Site Parent Based Intervention
Description: Parents in the interactive PBI condition will receive an interactive web-based SNS PBI with text message prompts aimed to reduce adolescent alcohol use and risky cognitions related to alcohol displays on SNS.
Study NCT04333966 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active Control
Description: Parents in the active control condition will receive an emailed copy of the Surgeon General's Call to Action: A Guide for Families.
Study NCT05514665 — intervention group
Intervention type: DEVICE
Intervention: Diffuse Optical Tomography
Description: Neonates once hemodynamically stable will undergo diffuse optical tomography measurements of functional brain connectivity at the bedside within 3-7 days after birth.
Study NCT06488781 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azithromycin
Description: Azithromycin 500 milligrams intravenously once and cefazolin 2 grams intravenously every 8 hours for up to three doses
Study NCT06488781 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo given in place of other two active drugs
Study NCT05718362 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Ayres Sensory Integration Therapy
Description: It is an intervention method whose effectiveness is questioned. It is a therapy program applied according to Ayres Sensory Integration Fidelity Measure.
Study NCT05718362 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Home Program
Description: These are the activities created for the participants (both intervention and control groups) and to be done in the home environment.
Study NCT05718362 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home Program
Description: These are the activities created for the participants (both intervention and control groups) and to be done in the home environment.
Study NCT06008002 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: M-TAPA block
Description: ultrasound guided Modified thoracoabdominal nerves block through perichondrial approach(M-TAPA) block (0.3 ml/kg , %0.25 bupivacaine) will be performed
Study NCT06008002 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: EXORA block
Description: Ultrasound guided External Oblique And Rectus Abdominis Plane (EXORA) Block block (0.3 ml/kg , %0.25 bupivacaine) will be performed
Study NCT06008002 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tramadol
Description: 400 mg tramadol, IV 4 mg/ mL tramadol solution into 100 mL normal saline; Patient-controlled analgesia settings: 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval, six-hour limit infusion to attain 100 mg. Maximum daily dose was set at 400 mg.
Study NCT06195579 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Transforming the Intense Child Workbook (Glasser, 2016)
Description: The NHA was delivered in a guided self-help format, using the Transforming the Intense Child workbook (Glasser, 2016) and weekly phone calls.
Study NCT05572281 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tasimelteon Oral Capsule
Description: No additional information
Study NCT05572281 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tasimelteon Oral Suspension
Description: No additional information
Study NCT06563362 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: De-escalation of irradiated volume
Description: De-escalation of elective clinical target volumes as recommended by a model-based approach
Study NCT06559345 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: TMLI
Description: The total dose of TMLI is 12 Gy, administered on days -7, -6, and -5, with 2 Gy per fraction, twice daily, for a total of 6 fractions.
Study NCT06559345 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: TBI
Description: The total dose of TBI is 12 Gy, administered on days -7, -6, and -5, with 2 Gy per fraction, twice daily, for a total of 6 fractions.
Study NCT06559345 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cyclophosphamide
Description: The total dose of cyclophosphamide is 120 mg/kg, administered over 2 days on days -4 and -3.
Study NCT06559345 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: The total dose of cyclophosphamide is 120 mg/kg, administered over 2 days on days -4 and -3.
Study NCT05755282 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Post-market foam alcohol-based hand sanitizer #1
Description: Automated dispenser will dispense 1 mL of hand sanitizer product onto hands.
Study NCT05755282 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Post-market foam alcohol-based hand sanitizer #2
Description: Automated dispenser will dispense 1 mL of hand sanitizer product onto hands.
Study NCT05457413 — intervention group
Intervention type: PROCEDURE
Intervention: Sleeve gastrectomy
Description: Bariatric surgery
Study NCT04730466 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neuropsychological rehabilitation
Description: The intervention can be carried out in the research unit or in the Parkinson's association. Each session will consist of a series of cognitive stimulation tasks aimed at improving attention, perception and processing speed. These tasks will be applied through the NeuronUp cognitive neurorehabilitation platform to achieve maximum homogeneity and objectivity in their application. The program is programmed and is identical for all patients. Performing tasks through the platform allows us to objectively record the performance of each patient in all tasks.
Study NCT06502340 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: high sensitive troponin I
Description: high-sensitive Troponin I levels
Study NCT06242613 — intervention group
Intervention type: PROCEDURE
Intervention: Robot-Assisted Gastrectomy
Description: Gastrectomy performed with a robotic system.
Study NCT06242613 — intervention group
Intervention type: PROCEDURE
Intervention: Laparoscopic Gastrectomy
Description: Gastrectomy performed with conventional laparoscopic approach.
Study NCT05487248 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood Sample Collection
Description: For subjects receiving treatments with a 2- or 4-weekly schedule, blood samples for ctDNA testing will be collected at the following timepoints:~* Before treatment start (day 1)~* 2 weeks after treatment start (day 15)~* 4 weeks after treatment start (day 29)~* 8 or 12 weeks after treatment start and every 8 or 12 weeks thereafter (i.e., at the same time of each imaging tumour assessment)~For subjects receiving treatments with a 3-weekly schedule, blood samples for ctDNA testing will be collected at the following timepoints:~* Before treatment start (day 1)~* 3 weeks after treatment start (day 22)~* 6 weeks after treatment start (day 43)~* 8 or 12 weeks after treatment start and every 8 or 12 weeks thereafter (i.e., at the same time of each imaging tumour assessment)
Study NCT05600621 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Incentivized Matched Youth Savings Accounts (YSA) with income-generating activities (IGAs)
Description: ALHIV will receive a YSA with a 1:1 matched savings program at a financial institution accredited by the Bank of Uganda. Each YDA will be opened in the name of the adolescent, with their primary caregiver as a co-signer, until the adolescent turns 18 years. The account will then be matched with money from the program on 1:1 rate.~As part of YSA, ALHIV are also trained on investing in income-generating activities (IGA) and are normally allowed to use up to 30% of their matched savings to invest in an IGA to benefit their family. The IGA portion helps promote economic stability for families and enable the ALHIV to afford medical expenses.
Study NCT05600621 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: A manualized visual-based intervention for ART adherence and stigma reduction using multiple family group approach (Suubi Cartoon).
Description: Participants assigned to this component will participate together with her/his caregiving family, in attending sixteen 60 minute sessions hosted within the community over 16 weeks. Each session involves 6-10 families. Participants will learn from the Suubi Cartoon curriculum about their HIV diagnosis and treatment needs, while coping with family loss, stigma, peer relationships, identity, and family functioning.
Study NCT04377945 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1, JM-010 component Group A
Description: JM-010 component Group A
Study NCT04377945 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1, JM-010 component Group B
Description: JM-010 component Group B
Study NCT05600621 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Engagement with HIV treatment-experienced role models who share lived experiences of HIV
Description: Participants will be assigned to small groups with an average of 3-4 peers from the same health clinic, and each ALHIV stays in the same group -- for 9 sessions - with the same role model. This is intended to build trust and rapport not only between the role model and mentee, but also between all group members. The 9 sessions, to be conducted over a 6-month period, include activities, videos, scenarios, and role-playing to facilitate discussion and learning. This is intended to promote their self-esteem, improve their HIV care engagement, reduce stigma and stress, encourage hopefulness, build stronger communication skills with their caregivers and/or family members, enhance safe sexual decision-making, and decrease sexual risk-taking behavior.
Study NCT05600621 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard of Care (SOC)
Description: SOC consisting of pediatric ART initiation and monitoring outlined by Uganda's Ministry of Health.
Study NCT05929937 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Opioids
Description: Patients will receive a prescription of 5 tablets of opioids (preferred: Oxycodone, or surgeon preference for Oxycodone intolerance)
Study NCT05929937 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: No opioids
Description: Standard of care, patients will not receive a prescription for opioids.
Study NCT06188702 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S095035
Description: S095035 will be taken orally once daily in 28-day cycle.
Study NCT04377945 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1, JM-010 component Group C
Description: JM-010 component Group C
Study NCT04377945 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Part 1, Placebo Group
Description: Placebo Group
Study NCT04377945 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 2, JM-010 combination Group A
Description: JM-010 combination Group A
Study NCT04377945 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 2, JM-010 combination Group B
Description: JM-010 combination Group B
Study NCT04377945 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 2, JM-010 component Group C
Description: JM-010 component Group C
Study NCT04377945 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Part 2, Placebo Group
Description: Placebo Group
Study NCT04946318 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CSJ117
Description: CSJ117 (0.5 mg, 1mg, 2mg, 4 mg and 8 mg) capsules for inhalation once daily delivered via Concept1 inhalation device for 12 or 24 weeks.
Study NCT04946318 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: CSJ117
Description: CSJ117 (0.5 mg, 1mg, 2mg, 4 mg and 8 mg) capsules for inhalation once daily delivered via Concept1 inhalation device for 12 or 24 weeks.
Study NCT04946318 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo inhaled once daily for 12 or 24 weeks. Delivered via Concept1 device.
Study NCT05187117 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CAPABLE Family - Open Label Pilot
Description: As in CAPABLE (NA_00031539), the delivery characteristics of CAPABLE Family consist of an assessment-driven, individually tailored package of interventions delivered over the course of 4 months by an occupational therapist (OT) (\~6 home visits for ≤ 1hour), a registered nurse (RN) (\~4 home visits for ≤ 1hour) and a handy worker (HW).~Adaptations for cognitive decline will be made on a per-client basis as part of the open-label pilot. Topics of adaptations include problem areas addresses, care partner involvement, length/frequency of visits, types of assessments and questions asked, and brainstorming/action planning structure.
Study NCT05187117 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CAPABLE Family - Randomized Control Trial
Description: As in CAPABLE (NA_00031539), the delivery characteristics of CAPABLE Family consist of an assessment-driven, individually tailored package of interventions delivered over the course of 4 months by an occupational therapist (OT) (\~6 home visits for ≤ 1hour), a registered nurse (RN) (\~4 home visits for ≤ 1hour) and a handy worker (HW). Refinements based on the open label pilot results will be included.
Study NCT05187117 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CAPABLE Family - Randomized Control Trial
Description: As in CAPABLE (NA_00031539), the delivery characteristics of CAPABLE Family consist of an assessment-driven, individually tailored package of interventions delivered over the course of 4 months by an occupational therapist (OT) (\~6 home visits for ≤ 1hour), a registered nurse (RN) (\~4 home visits for ≤ 1hour) and a handy worker (HW). Refinements based on the open label pilot results will be included.
Study NCT06025370 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Prone Position
Description: All healthy volunteers will be positioned in prone position, on a bed equipped with a mapping pressure system.~The volunteers will spend 5 minutes in each of the positions corresponding to the study groups.
Study NCT06025370 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prone Position
Description: All healthy volunteers will be positioned in prone position, on a bed equipped with a mapping pressure system.~The volunteers will spend 5 minutes in each of the positions corresponding to the study groups.
Study NCT04944225 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Opioid Reduction Strategy
Description: The intervention will involve a multi-faceted 3 component approach involving 1) opioid prescription caps (default maximum number of tablets for discharge prescriptions, as defined by evidence-based guidelines) 2) patient education tools (e.g. What is a normal pain trajectory? How to manage the pain? Benefits and potential harms of pharmacologic analgesia. Non-pharmacologic analgesia management? What to do if pain is excessive?), 3) provider education tools (e.g. including procedure-specific evidence-based recommendations for multi-modal analgesia; comparison of local baseline prescribing patterns with exemplary prescribing patterns; defining targeted reduction if baseline prescribing is at odds with best evidence; review of best evidence about optimal analgesia perioperatively), and 4) bi-weekly cumulative prescriber feedback on opioid prescribing patterns post-intervention and until end-of-study.
Study NCT03903471 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 22G-ProCore Endobronchial Ultrasound Needle
Description: EchoTip Procore® Endobronchial HD Ultrasound Biopsy Needle, COOK
Study NCT03903471 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 22G-Standard Endobronchial Ultrasound Needle
Description: EchoTip® Ultra Endobronchial High Definition Ultrasound Needle, COOK
Study NCT06003179 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Conditioning chemo at different doses
Study NCT06365606 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iStatis Syphilis Ab Test
Description: Capillary (fingerstick) blood, venous whole blood and plasma samples prospectively collected from the participants will be tested on the iStatis Syphilis Ab Test.
Study NCT06458829 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: SEARCH-AF
Description: SEARCH-AF program will include opportunistic screening among old adults during primary care visits and promoting strategies. Promoting strategies will be developed based on the Consolidated Framework for Implementation Research framework which may include leadership engagement, policy support, providing screening resources, atrial fibrillation screening and management training. General practitioner or nurse in each health care center will implement point-on-care screening. The intervention will last for six months and followed up for another six months.
Study NCT05502588 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-Guided Forest Bathing
Description: Participants will participate in two, 60-90 minute self-guided forest bathing sessions over the course of a year in one of four Vancouver, B.C. park trails and be given prompts to consciously use their five senses in the forest.
Study NCT05502588 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Guided Forest Bathing
Description: Participants will participate in two, 60-90 minute guided forest bathing sessions over the course of a year in one of four Vancouver, B.C. park trails. They will be invited by a certified forest therapy guide to consciously use their five senses in the forest.
Study NCT06458829 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SEARCH-AF
Description: SEARCH-AF program will include opportunistic screening among old adults during primary care visits and promoting strategies. Promoting strategies will be developed based on the Consolidated Framework for Implementation Research framework which may include leadership engagement, policy support, providing screening resources, atrial fibrillation screening and management training. General practitioner or nurse in each health care center will implement point-on-care screening. The intervention will last for six months and followed up for another six months.
Study NCT06090474 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NDC-002
Description: Combination of NDC-002B and NDC-002C
Study NCT04802746 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alprazolam
Description: Study participants will receive Staccato alprazolam Dose 1 and Staccato alprazolam Dose 2 at pre-specified time points in Part A. Study participants will receive single dose of Staccato alprazolam at pre-specified time points in Part B.
Study NCT04802746 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Study participants will receive Staccato placebo at pre-specified time points in Part A and Part B matching the pre-specified Staccato alprazolam dosing.
Study NCT04802746 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Study participants will receive Staccato placebo at pre-specified time points in Part A and Part B matching the pre-specified Staccato alprazolam dosing.